Clinical Trials Directory

Trials / Terminated

TerminatedNCT02590783

Treatment of Pelvic Ring Fractures in the Elderly

Treatment of Pelvic Ring Fractures in the Elderly: A Randomized Controlled Trial Comparing Surgical vs. Conservative Therapy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Pelvic ring fractures in the elderly are associated with high morbidity during standard conservative treatment due to immobility. Furthermore the risk of long term dependence even after the fracture has united is high. In analogy to the treatment of hip fractures in a similar patient population, patients might benefit from surgical treatment due to a reduction in pain and early mobilization.

Detailed description

Comparison of surgical vs conservative treatment with respect to mobility, pain, morbidity and mortality.

Conditions

Interventions

TypeNameDescription
PROCEDUREexperimental intervention surgeryPatients are placed supine on the carbon table. Screw paths are planned on a spiral CT scan from the sacrum on transversal slices, two Kirschner-wires 2.5 mm in diameter are introduced into the iliac bone through a stab incision and advanced into the ilio-sacral joint, through the lateral part of sacrum into the first and second sacral body, through the contralateral lateral part of the sacrum and exiting the contralateral iliac bone through the sacra-iliac joint with aid of CT-guidance. Over the Kirschner-wires 7.0 mm cannulated screws are introduced and the Kirschner-wires withdrawn. Several low-dose computer tomography scans are performed to secure the correct position. Total radiation dose is 300 mille gray square centimetres (mGycm).
PROCEDUREcontrol interventionMobilization guided by our physiotherapists. Full weight bearing is allowed. Analgetic treatment with metamizol, ibuprofen or paracetamol to the attending physicians discretion under regular surveillance laboratory values and/ or morphine or methadone. Patients will be treated with an individually based approach, if necessary involving our anesthesiologic pain service. Thrombo-embolic prophylaxis with a low molecular weight heparin or rivaroxaban for 6 weeks unless there is an indication for oral anticoagulation. All patients will be followed up by the Geriatric Fracture Center considering osteoporosis, fall prophylaxis, malnutrition and delirium. For the duration of the study the patients will not receive Parathyroid Hormone Substitution or Phosphonates.

Timeline

Start date
2017-10-17
Primary completion
2022-07-11
Completion
2022-07-11
First posted
2015-10-29
Last updated
2024-05-14

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02590783. Inclusion in this directory is not an endorsement.